Metropolis Healthcare Limited (METROPOLIS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has a cash flow conversion efficiency ratio of 0.091x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.32 Billion ≈ $14.25 Million USD) by net assets (Rs14.43 Billion ≈ $156.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See METROPOLIS net asset quality index to measure how much of total assets are equity-financed.
Metropolis Healthcare Limited - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Metropolis Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Metropolis Healthcare Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Metropolis Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Metropolis Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tiv Taam
TA:TTAM
|
0.162x |
|
Perpetual Equity Investment Company Ltd
AU:PIC
|
-0.011x |
|
Shoper S.A.
WAR:SHO
|
0.225x |
|
Cre8 Direct Ningbo Co Ltd
SHE:300703
|
0.055x |
|
Sophia Genetics SA
NASDAQ:SOPH
|
-0.145x |
|
Ningbo Water Meter Co Ltd
SHG:603700
|
0.020x |
|
Zoneco Group Co Ltd
SHE:002069
|
0.203x |
|
Guangdong Liantai Environmental Protection Co Ltd
SHG:603797
|
0.040x |
Annual Cash Flow Conversion Efficiency for Metropolis Healthcare Limited (2014–2025)
The table below shows the annual cash flow conversion efficiency of Metropolis Healthcare Limited from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see METROPOLIS company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs13.35 Billion ≈ $144.34 Million |
Rs2.63 Billion ≈ $28.41 Million |
0.197x | -18.05% |
| 2024-03-31 | Rs10.99 Billion ≈ $118.88 Million |
Rs2.64 Billion ≈ $28.56 Million |
0.240x | -3.68% |
| 2023-03-31 | Rs9.91 Billion ≈ $107.14 Million |
Rs2.47 Billion ≈ $26.72 Million |
0.249x | -12.54% |
| 2022-03-31 | Rs8.88 Billion ≈ $96.05 Million |
Rs2.53 Billion ≈ $27.39 Million |
0.285x | -18.92% |
| 2021-03-31 | Rs7.08 Billion ≈ $76.57 Million |
Rs2.49 Billion ≈ $26.93 Million |
0.352x | -14.09% |
| 2020-03-31 | Rs5.25 Billion ≈ $56.79 Million |
Rs2.15 Billion ≈ $23.25 Million |
0.409x | +90.72% |
| 2019-03-31 | Rs4.20 Billion ≈ $45.42 Million |
Rs901.51 Million ≈ $9.75 Million |
0.215x | -11.37% |
| 2018-03-31 | Rs4.29 Billion ≈ $46.41 Million |
Rs1.04 Billion ≈ $11.24 Million |
0.242x | -18.09% |
| 2017-03-31 | Rs3.44 Billion ≈ $37.22 Million |
Rs1.02 Billion ≈ $11.00 Million |
0.296x | -4.95% |
| 2016-03-31 | Rs2.94 Billion ≈ $31.78 Million |
Rs914.16 Million ≈ $9.89 Million |
0.311x | +72.03% |
| 2015-03-31 | Rs3.84 Billion ≈ $41.56 Million |
Rs694.91 Million ≈ $7.52 Million |
0.181x | -25.29% |
| 2014-03-31 | Rs3.18 Billion ≈ $34.37 Million |
Rs769.22 Million ≈ $8.32 Million |
0.242x | -- |
About Metropolis Healthcare Limited
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more